Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-based Medicaments Versus Double Antibiotic Paste in Managing Non-vital Primary Molars
NCT06926322Enrolling by invitation
- Sponsor
- Ain Shams University
- Start
- Jul 2025
- Primary completion
- Aug 2027
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Randomised, single-blind trial of chitosan-coated silver nanoparticles in dental pulp necrosis (3 arms), sponsored by Ain Shams University. Primary endpoints: Clinical success at 12 months and Radiographic success at 12 months. Started Jul 2025; status: enrolling by invitation.
02
Drugs
chitosan-coated silver nanoparticles
03
Conditions
dental pulp necrosis
Beyond the preview
Go deeper on NCT06926322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06926322.